Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MMP14 | P50281 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 4/20 | 0.40 |
| ▸ | PPARD | Q03181 | 4/20 | 0.40 |
| ▸ | PPARA | Q07869 | 4/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17908801 | 1.00 | CYP3A4 (0.57) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL17909449 | 1.00 | CYP3A4 (0.57) | CYP3A4MMP9MMP8MMP14TSHR | |
| Adipic Acid SCHEMBL14672589 | 0.95 | CYP3A4 (0.55) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL9478686 | 0.91 | CYP3A4 (0.57) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL26964272 | 0.89 | CYP3A4 (0.57) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL26034704 | 0.88 | CYP3A4 (0.57) | CYP3A4MMP9MMP8MMP14TSHR | |
| Adipic Acid SCHEMBL9700310 | 0.87 | TSHR (0.62) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL28323520 | 0.86 | CYP3A4 (0.54) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL17909574 | 0.85 | CYP3A4 (0.56) | CYP3A4MMP9MMP8MMP14TSHR | |
| SCHEMBL17909428 | 0.85 | CYP3A4 (0.74) | CYP3A4MMP9MMP8MMP14TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3441382-B1 | OXA ACID COMPOUND | MORESCO CORP (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-11021430-B2 | Oxa acid compound | MORESCO CORPORATION (JP) | 2021-06-01 | — | — | US | disclosed |
| US-20190106373-A1 | OXA ACID COMPOUND | MORESCO CORPORATION (JP) | 2019-04-11 | — | — | US | disclosed |
| EP-3048093-B1 | ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF | MORESCO CORP (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-10077229-B2 | Ether-containing monoester compound and use thereof | MORESCO CORPORATION (JP) | 2018-09-18 | — | — | US | disclosed |
| EP-3048093-A1 | ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF | Moresco Corporation (JP) | 2016-07-27 | — | — | EP | disclosed |
| US-20160200998-A1 | ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF | MORESCO CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106373-A1 | OXA ACID COMPOUND | OXA1L, ACOX1, ALOX12 | CYP3A4 2677/4885MMP9 593/4885MMP8 735/4885 |
| US-10077229-B2 | Ether-containing monoester compound and use thereof | SFN, CCNE2, HSD3B2 | CYP3A4 281/4885MMP9 2704/4885MMP8 3340/4885 |
| US-11021430-B2 | Oxa acid compound | OXA1L, ACOX1, OLA1 | CYP3A4 2117/4885MMP9 361/4885MMP8 547/4885 |
| US-20160200998-A1 | ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF | SFN, CCNE2, MSMO1 | CYP3A4 341/4885MMP9 2459/4885MMP8 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.